HBAN
56
2
LRCX
45
6
FLS
75
2
VRSK
77
4
ROST
52
5
BA
49
-3
AAL
53
-4
CVS
50
2
ES
31
3
EXPE
91
3
EOG
56
-2
ABT
62
5
PCAR
56
3
KHC
11
2
TROW
51
3
KLAC
43
4
ROP
59
5
CAT
62
7
AIG
44
6
MA
57
2
HBAN
56
2
LRCX
45
6
FLS
75
2
VRSK
77
4
ROST
52
5
BA
49
-3
AAL
53
-4
CVS
50
2
ES
31
3
EXPE
91
3
EOG
56
-2
ABT
62
5
PCAR
56
3
KHC
11
2
TROW
51
3
KLAC
43
4
ROP
59
5
CAT
62
7
AIG
44
6
MA
57
2
Financhill
Back

Virtus LifeSci Biotech Clinical Trls ETF Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
26.53
Seasonality Move:
8.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Virtus LifeSci Biotech Clinical Trls ETF Stock Forecast

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 7.5% based on the past 9 years of stock performance.
  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Virtus LifeSci Biotech Clinical Trls ETF Stock Undervalued?
    The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $26.12. The Score for BBC is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Virtus LifeSci Biotech Clinical Trls ETF Stock Go Up Next Year?

  • Over the next 52 weeks, Virtus LifeSci Biotech Clinical Trls ETF has on average historically risen by 7.5% based on the past 9 years of stock performance.

Virtus LifeSci Biotech Clinical Trls ETF Stock Rating

Sell
33
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF overpriced?

  • Virtus LifeSci Biotech Clinical Trls ETF has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Virtus LifeSci Biotech Clinical Trls ETF Stock Price History

Is BBC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
31.99
52-Week Low:
18.77

Prediction Charts

Market Cap:
0
Price in USD:
26.12
Volume:
1.86K
Beta:
1.29

Technical Analysis

SMA50:
28.70
SMA100:
28.09
SMA200:
27.79
52-Wk Change:
39.25%

Stock Predictions

  • Is Virtus LifeSci Biotech Clinical Trls ETF stock public?
    Yes, Virtus LifeSci Biotech Clinical Trls ETF is a publicly traded company.
  • What is the Virtus LifeSci Biotech Clinical Trls ETF stock quote today?
    The Virtus LifeSci Biotech Clinical Trls ETF stock price is 26.12 USD today.
  • How to buy Virtus LifeSci Biotech Clinical Trls ETF stock online?
    You can buy Virtus LifeSci Biotech Clinical Trls ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 29.40 29.24 29.41 29.24
Nov-5 28.92 29.54 29.54 28.89
Nov-6 29.95 30.60 30.60 29.95
Nov-7 30.73 30.72 30.85 30.66
Nov-8 30.82 31.05 31.05 30.82
Nov-11 31.37 31.34 31.65 31.34
Nov-12 30.79 29.83 30.79 29.83
Nov-13 30.07 29.28 30.48 29.28
Nov-14 29.23 28.35 29.25 28.35
Nov-15 28.00 26.53 28.00 26.53
Nov-18 26.50 26.10 26.51 26.09
Nov-19 26.01 26.34 26.34 25.81
Nov-20 26.13 26.17 26.35 26.00
Nov-21 25.98 26.12 26.32 25.91

Virtus LifeSci Biotech Clinical Trls ETF Earnings

Data Unavailable

Virtus LifeSci Biotech Clinical Trls ETF Forecast Revenue Growth

Data Unavailable

* Virtus LifeSci Biotech Clinical Trls ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.